These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6168882)

  • 1. A nonfunctional protein in human leukemia cells reacts with antiserum to dihydrofolate reductase from L1210 leukemia cells.
    Iqbal MP; Rothenberg SP
    Life Sci; 1981 Aug; 29(7):689-96. PubMed ID: 6168882
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic heterogeneity of dihydrofolate reductase from methotrexate sensitive and resistant L1210 leukemia cells.
    Iqbal MP; Rothenberg SP; Larosa C
    Proc Soc Exp Biol Med; 1985 Oct; 180(1):98-102. PubMed ID: 2412235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human leukemia and normal leukocytes contain a species of immunoreactive but nonfunctional dihydrofolate reductase.
    Rothenberg SP; Iqbal MP
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):645-9. PubMed ID: 6952216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a high-molecular-weight nonfunctional protein in L1210 leukemia cells with common antigenic determinants to dihydrofolate reductase.
    Rothenberg SP; Iqbal MP
    Cancer Res; 1983 Feb; 43(2):529-35. PubMed ID: 6184148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple forms of L1210 dihydrofolate reductase differing in affinity for methotrexate.
    Duffy TH; Beckman SB; Huennekens FM
    Biochem Biophys Res Commun; 1984 Feb; 119(1):352-8. PubMed ID: 6704125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for kinetic and immunologic heterogeneity of dihydrofolate reductase in L1210 leukemia cells.
    Iqbal MP; Rothenberg SP; da Costa M
    Biochem Med Metab Biol; 1991 Oct; 46(2):196-207. PubMed ID: 1782010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.
    Matherly LH; Barlowe CK; Goldman ID
    Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate and inhibitor complexes of dihydrofolate reductase from amethopterin-resistant L1210 cells.
    Neef VG; Huennekens FM
    Arch Biochem Biophys; 1975 Dec; 171(2):435-43. PubMed ID: 959
    [No Abstract]   [Full Text] [Related]  

  • 9. A fluorescent analogue of methotrexate as a probe for folate antagonist molecular receptors.
    Susten SS; Kempton RJ; Black AM; Freisheim JH
    Biochem Pharmacol; 1984 Jun; 33(12):1957-62. PubMed ID: 6732854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydrofolate reductase activity of leukemia L1210 during development of methotrexate resistance.
    Schrecker AW; Mead JA; Greenberg NH; Goldin A
    Biochem Pharmacol; 1971 Mar; 20(3):716-8. PubMed ID: 5150168
    [No Abstract]   [Full Text] [Related]  

  • 11. Dialkyl esters of methotrexate and 3',5'-dichloromethotrexate: synthesis and interaction with aldehyde oxidase and dihydrofolate reductase.
    Johns DG; Farquhar D; Wolpert MK; Chabner BA; Loo TL
    Drug Metab Dispos; 1973; 1(3):580-9. PubMed ID: 4149453
    [No Abstract]   [Full Text] [Related]  

  • 12. Dihydrofolate reductase from a resistant subline of the L1210 lymphoma. Purification and properties.
    Perkins JP; Hillcoat BL; Bertino JR
    J Biol Chem; 1967 Oct; 242(20):4771-6. PubMed ID: 4964810
    [No Abstract]   [Full Text] [Related]  

  • 13. Lack of intracellular conversion of dihydrohomofolate to tetrahydrohomofolate in leukemia cells with high levels of dihydrofolate reductase.
    Nahas A; Friedkin M
    Mol Pharmacol; 1972 May; 8(3):353-61. PubMed ID: 5040933
    [No Abstract]   [Full Text] [Related]  

  • 14. Quinazoline antifolates as inhibitors of dihydrofolate reductase from human leukemia cells.
    Johns DG; Capizzi RL; Nahas A; Cashmore AR; Bertino JR
    Biochem Pharmacol; 1970 Apr; 19(4):1528-33. PubMed ID: 5284463
    [No Abstract]   [Full Text] [Related]  

  • 15. Limited effectiveness of in vitro high-dose methotrexate and leucovorin to overcome resistance in L1210 leukemia cells with elevations of dihydrofolate reductase.
    Bruckner H; Rubinoff M; Waxman S
    Eur J Cancer (1965); 1980 Aug; 16(8):1057-63. PubMed ID: 6969180
    [No Abstract]   [Full Text] [Related]  

  • 16. Variation of dihydrofolate reductase activity during in vitro and in vivo growth of sublines of L1210 lymphoma.
    Hillcoat BL
    J Natl Cancer Inst; 1971 Jan; 46(1):75-80. PubMed ID: 5546195
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship between intracellular dihydrofolate reductase and tightly bound intracellular methotrexate in human neoplastic cells.
    Bender RA; Makulu DR
    Biochem Pharmacol; 1976 Apr; 25(8):975-6. PubMed ID: 1063571
    [No Abstract]   [Full Text] [Related]  

  • 18. Mouse brain contains a high molecular weight nonfunctional protein with antigenic homology to dihydrofolate reductase.
    Iqbal MP; Rothenberg SP; LaRosa C
    Biochem Biophys Res Commun; 1986 Nov; 141(1):258-62. PubMed ID: 3800999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rescue effect of exogenous reduced folates on methotrexate polyglutamylation and dihydrofolate reductase activity in L1210 cells.
    Balińska M
    Acta Biochim Pol; 1988; 35(3):199-205. PubMed ID: 2469275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of methotrexate polyglutamates in L1210 murine leukemia cells.
    Whitehead VM
    Cancer Res; 1977 Feb; 37(2):408-12. PubMed ID: 832265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.